Harnessing Avidity: Quantifying the Entropic and Energetic Effects of Linker Length and Rigidity for Multivalent Binding of Antibodies to HIV-1
Abstract
IgG antibodies increase their apparent affinities by using both of their Fabs to simultaneously attach to antigens. HIV-1 foils this strategy by having few, and highly separated, Envelope (Env) spike targets for antibodies, forcing most IgGs to bind monovalently. Here, we develop a statistical mechanics model of synthetic diFabs joined by DNA linkers of different lengths and flexibilities. This framework enables us to translate the energetic and entropic effects of the linker into the neutralization potency of a diFab. We demonstrate that the strongest neutralization potencies are predicted to require a rigid linker that optimally spans the distance between two Fab binding sites on an Env trimer and that avidity can be further boosted by incorporating more Fabs into these constructs. These results inform the design of multivalent anti-HIV-1 therapeutics that utilize avidity effects to remain potent against HIV-1 in the face of the rapid mutation of Env spikes.
Additional Information
© 2019 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). Received 22 May 2019, Revised 10 September 2019, Accepted 17 September 2019, Available online 23 October 2019. We thank Anthony Bartolotta, Justin Bois, Jim Eisenstein, Vahe Galstyan, Peng He, Willem Kegel, David Hsieh, Giacomo Koszegi, Pankaj Mehta, Jiseon Min, Olexei Motrunich, Noah Olsman, Vahe Singh, and Richard Zhu for useful discussions; Christopher Barnes for measuring modeled 3BNC60-Env complexes; and Marta Murphy for help preparing figures. This research was supported by NIH NIAID grants 1R01AI129784 and HIVRAD P01 AI100148 (P.J.B.), the Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery grant 1040753 (P.J.B.), La Fondation Pierre-Gilles de Gennes (R.P.), the Rosen Center at Caltech (R.P.), 1R35 GM118043-01 Maximizing Investigators' Research Award (MIRA), United States, and R01 GM085286 (R.P.), and a Caltech-COH Biomedical Research Initiative (P.J.B.). We thank the Burroughs Wellcome Fund for their support through the Career Award at the Scientific Interface (S.Y.) as well as for the Physiology Course at the Marine Biological Laboratory where part of this work was done. Author Contributions: T.E., A.P.W., R.P., and P.J.B. conceived the project. T.E., S.Y., and R.P. developed the model and performed analyses. T.E., R.P., and P.J.B. wrote the paper with input from other authors. The authors declare no competing interests.Attached Files
Published - 1-s2.0-S2405471219303151-main.pdf
Supplemental Material - 1-s2.0-S2405471219303151-mmc1.pdf
Supplemental Material - 1-s2.0-S2405471219303151-mmc2.zip
Supplemental Material - 1-s2.0-S2405471219303151-mmc3.mp4
Files
Additional details
- PMCID
- PMC6892280
- Eprint ID
- 99410
- Resolver ID
- CaltechAUTHORS:20191023-142258650
- NIH
- 1R01AI129784
- NIH
- P01 AI100148
- Bill and Melinda Gates Foundation
- 1040753
- La Fondation Pierre-Gilles de Gennes
- Donna and Benjamin M. Rosen Bioengineering Center
- NIH
- 1R35 GM118043-01
- NIH
- R01 GM085286
- Caltech-City of Hope Biomedical Initiative
- Burroughs Wellcome Fund
- Marine Biological Laboratory
- Created
-
2019-10-23Created from EPrint's datestamp field
- Updated
-
2022-02-16Created from EPrint's last_modified field
- Caltech groups
- Rosen Bioengineering Center